Mauricio, D, Escalada, J, Pérez, A, Romero-Gómez, M, Cusi, K, Younoussi, ZM, Lazarus, JV. Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists. Endocrinologia Diabetes y Nutricion. 2024; 71(4)DOI:10.1016/j.endien.2024.01.007. PMID:38735676. IF:1.800(Q3/8D).

Barranco-Altirriba, M, Alonso, N, Weber, RJM, Lloyd, GR, Hernandez, M, Yanes, O, Capellades, J, Jankevics, A, Winder, C, Falguera, M, Franch-Nadal, J, Dunn, WB, Perera-Lluna, A, Castelblanco, E, Mauricio, D. Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus. Cardiovascular Diabetology. 2024; 23(1)DOI:10.1186/s12933-024-02202-5. PMID:38553758. IF:10.600(Q1/1D).

Folle, AM, Magallanes, SL, Fló, M, Alvez-Rosado, R, Carrión, F, Vallejo, C, Watson, D, Julve, J, González-Sapienza, G, Pristch, O, González-Techera, A, Ferreira, AM. Modulatory actions of Echinococcus granulosus antigen B on macrophage inflammatory activation. Frontiers in Cellular and Infection Microbiology. 2024; 14DOI:10.3389/fcimb.2024.1362765. PMID:38562963. IF:4.800(Q1/2D).

Monroy, G, Fernández, C, Altimira, L, Barba, U, Corcoy, R. Postpartum oral glucose tolerance test in women with prior gestational diabetes. Does breastfeeding affect the results? Analysis of hormonal profiles. DIABETIC MEDICINE. 2024; 41(6)DOI:10.1111/dme.15315. PMID:38451734. IF:3.400(Q2/4D).

Xie X., Liu J., García-Patterson A., Chico A., Mateu-Salat M., Amigó J., Adelantado J.M., Corcoy R.. Gestational weight gain in women with type 1 and type 2 diabetes mellitus is related to both general and diabetes-related clinical characteristics. Hormones-International Journal of Endocrinology and Metabolism. 2024; 23(1)DOI:10.1007/s42000-023-00497-9. PMID:37845472. IF:2.500(Q3/7D).

Vlacho, B, Fernandez-Camins, B, Canudas-Ventura, A, Rodríguez, A, Mollo, A, Claramunt, FXC, Antentas, M, Mauricio, D, Franch-Nadal, J. Performance of Primary Care Physicians in the Management of Glycemia, Lipids, and Blood Pressure among People with Type 2 Diabetes: A Cross-Sectional Study. Journal of Clinical Medicine. 2024; 13(6)DOI:10.3390/jcm13061544. PMID:38541770. IF:2.900(Q1/2D).

Ramírez-Morros, A, Franch-Nadal, J, Real, J, Miró-Catalina, Q, Bundó, M, Vlacho, B, Mauricio, D. Clinical characteristics and degree of cardiovascular risk factor control in patients with newly-diagnosed type 2 diabetes in Catalonia. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1339879. PMID:38390201. IF:4.600(Q1/3D).

Ma, CX, Ma, XN, Liu, JJ, Guan, CH, Li, YD, Zhao, N, Mauricio, D, Fu, SB. The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2024; 581DOI:10.1016/j.mce.2023.112113. PMID:37989409. IF:3.600(Q2/4D).

Beato-Víbora, PI, Chico, A, Moreno-Fernandez, J, Bellido-Castañeda, V, Nattero-Chávez, L, Picón-César, MJ, Martínez-Brocca, MA, Giménez-Alvarez, M, Aguilera-Hurtado, E, Climent-Biescas, E, Azriel-Mir, S, Rebollo-Román, A, Yoldi-Vergara, C, Pazos-Couselo, M, Alonso-Carril, N, Quirós, C. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. DIABETES CARE. 2024; 47(2)DOI:10.2337/dc23-1355. PMID:37948469. IF:16.600(Q1/1D).

Sloan, L, Cheng, AYY, Escalada, J, Haluzík, M, Mauricio, D. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review. DIABETES OBESITY & METABOLISM. 2024; 26(4)DOI:10.1111/dom.15425. PMID:38225217. IF:5.700(Q1/2D).

Rotllan N, Julve J, Escolà-Gil JC. Type 2 Diabetes and HDL dysfunction: a key contributor to Glycemic Control.. CURRENT MEDICINAL CHEMISTRY. 2024; 31(3)DOI:10.2174/0929867330666230201124125. PMID:36722477. IF:3.500(Q2/4D).

Chico A., Moreno-Fernández J., Fernández-García D., Solá E.. The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization. Diabetes Therapy. 2024; 15(1)DOI:10.1007/s13300-023-01486-2. PMID:37857988. IF:2.600(Q3/6D).

Rodríguez-Agudo, R, González-Recio, I, Serrano-Maciá, M, Bravo, M, Petrov, P, Blaya, D, Herranz, JM, Mercado-Gómez, M, Rejano-Gordillo, CM, Lachiondo-Ortega, S, Gil-Pitarch, C, Azkargorta, M, Van Liempd, SM, Martinez-Cruz, LA, Simao, AL, Elortza, F, Martín, C, Nevzorova, YA, Cubero, FJ, Delgado, TC, Argemi, J, Bataller, R, Schoonjans, K, Banales, JM, Castro, RE, Sancho-Bru, P, Avila, MA, Julve, J, Jover, R, Mabe, J, Simon, J, Goikoetxea-Usandizaga, N, Martínez-Chantar, ML. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1. Jhep Reports. 2024; 6(1)DOI:10.1016/j.jhepr.2023.100918. PMID:38192540. IF:7.500(Q1/2D).

Soldevila B., Alarcón L., Vlacho B., Real J., Hernández M., Cos X., Franch-Nadal J., Mauricio D.. Trends in the prevalence of gestational diabetes in Catalonia from 2010 to 2019. Primary Care Diabetes. 2024; 18(2)DOI:10.1016/j.pcd.2023.12.007. PMID:38228411. IF:2.300(Q2/5D).

Gómez-Peralta, F, Valledor, X, López-Picado, A, Abreu, C, Fernández-Rubio, E, Cotovad, L, Pujante, P, García-Fernández, E, Azriel, S, Corcoy, R, Pérez-González, J, Ruiz-Valdepeñas, L. Ultrarapid Insulin Use Can Reduce Postprandial Hyperglycemia and Late Hypoglycemia, Even in Delayed Insulin Injections: A Connected Insulin Cap-Based Real-World Study. Diabetes Technology & Therapeutics. 2024; 26(1)DOI:10.1089/dia.2023.0321. PMID:37902762. IF:6.300(Q1/2D).

Ramírez-Morros, A, Berenguera, A, Millaruelo, L, Buil-Cosiales, P, Garcia, CG, Cos, X, Lachica, LA, Artola, S, Millaruelo, JM, Mauricio, D, Franch-Nadal, J. Impact of Gender on Patient Experiences of Self-Management in Type 2 Diabetes: A Qualitative Study. Patient Preference and Adherence. 2024; 18DOI:10.2147/PPA.S466931. PMID:39290823. IF:2.000(Q2/4D).

Durán-Martínez, M, Azriel, S, Doulatram-Gamgaram, VK, Moreno-Pérez, O, Pines-Corrales, PJ, Tejera-Pérez, C, Merino-Torres, JF, Brito-Sanfiel, M, Chico, A, Marco, A, García-Fernández, E, Martínez-Montoro, JI. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study. DIABETES & METABOLISM. 2024; 50(1)DOI:10.1016/j.diabet.2023.101501. PMID:38061425. IF:4.700(Q1/3D).

Escalada J., Pérez A., Rica I.. Is the Spanish type 1 diabetes mellitus registry really necessary?. Endocrinologia Diabetes y Nutricion. 2023; 70(10)DOI:10.1016/j.endinu.2023.05.002. PMID:38000969. IF:1.800(Q3/8D).

López-Yerena, A, Padro, T, Villaplana, VD, Muñoz-García, N, Pérez, A, Vilahur, G, Badimon, L. Vascular and Platelet Effects of Tomato Soffritto Intake in Overweight and Obese Subjects. Nutrients. 2023; 15(24)DOI:10.3390/nu15245084. PMID:38140343. IF:4.800(Q1/2D).

Roth, L, Dogan, S, Tuna, BG, Aranyi, T, Benitez, S, Borrell-Pages, M, Bozaykut, P, De Meyer, GRY, Duca, L, Durmus, N, Fonseca, D, Fraenkel, E, Gillery, P, Giudici, A, Jaisson, S, Johansson, M, Julve, J, Lucas-Herald, AK, Martinet, W, Maurice, P, McDonnell, BJ, Ozbek, EN, Pucci, G, Pugh, CJA, Rochfort, KD, Roks, AJM, Rotllan, N, Shadiow, J, Sohrabi, Y, Spronck, B, Szeri, F, Terentes-Printzios, D, Aydin, ET, Tura-Ceide, O, Ucar, E, Yetik-Anacak, G. Pharmacological modulation of vascular ageing: A review from VascAgeNet. AGEING RESEARCH REVIEWS. 2023; 92DOI:10.1016/j.arr.2023.102122. PMID:37956927. IF:12.500(Q1/1D).

Frontino, G, Succurro, E, Corcoy, R, Scialabba, F, Poloniato, A, Scavini, M. Current and future trends in gestational diabetes diagnosis, care and neonatal outcomes. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1270472. PMID:38098867. IF:3.900(Q2/3D).

Pérez, A, Redondo-Antón, J, Romera, I, Lizán, L, Santos, MRD, Díaz-Cerezo, S, Orozco-Beltran, D. Disease and Economic Burden of Poor Metabolic and Weight Control in Type 2 Diabetes in Spain: A Systematic Literature Review. Diabetes Therapy. 2023; DOI:10.1007/s13300-023-01503-4. PMID:37989829. IF:2.800(Q3/6D).

Mauricio, D, Gratacòs, M, Franch-Nadal, J. Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves. Cardiovascular Diabetology. 2023; 22(1)DOI:10.1186/s12933-023-02056-3. PMID:37968679. IF:8.500(Q1/1D).

García E., Gil P., Miñambres I., Benitez-Amaro A., Rodríguez C., Claudi L., Julve J., Benitez S., Sánchez-Quesada J.L., Rives J., Garcia-Moll X., Vilades D., Perez A., Llorente-Cortes V.. Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1236487. PMID:37635956. IF:3.900(Q2/3D).

Torres-Méndez J.K., Niño-Narvión J., Martinez-Santos P., Diarte-Añazco E.M.G., Méndez-Lara K.A., del Olmo T.V., Rotllan N., Julián M.T., Alonso N., Mauricio D., Camacho M., Muñoz J.P., Rossell J., Julve J.. Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms. Nutrients. 2023; 15(14)DOI:10.3390/nu15143083. PMID:37513501. IF:4.800(Q1/2D).

Velilla, TA, Guijarro, C, Ruiz, RC, Piñero, MR, Marcos, JF, Pérez, AP, López, AMB, López, AM, Donaire, JAG, Obaya, JC, Guerra, LC, Carratalá, VP, Cabello, IE, Lazo, MS, Rodrigo, MMC, Prieto, JMM, Doblas, JJG, Soto, AB. Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: what parameters should a basic lipid profile include?. ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO. 2023; 4(2)DOI:10.1515/almed-2023-0047. PMID:38075943. IF:(Q/D).

Miñambres I, de Hollanda A, Vilarrasa N, Pellitero S, Rubio MA, Flores L, Caixàs A, Lobo S, Martinez Salamanca JI, Acevedo B, Moizé V, Andreu A, Escalada J. Obesity and fertility. Position statement.. Endocrinologia Diabetes y Nutricion. 2023; 70 Suppl 1DOI:10.1016/j.endien.2023.03.003. PMID:36907798. IF:(Q/D).

Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. Endocrinologia Diabetes y Nutricion. 2023; 70(7)DOI:10.1016/j.endinu.2023.02.002. PMID:37268528. IF:1.800(Q3/8D).

Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles: ¿qué parámetros debe incluir un perfil lipídico básico?. ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO. 2023; 4(2)DOI:10.1515/almed-2023-0010. PMID:. IF:(Q/D).

Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. Cirugia Cardiovascular. 2023; 30(3)DOI:10.1016/j.circv.2023.02.001. PMID:. IF:(Q/D).

Velilla T.A., Guijarro C., Ruiz R.C., Piñero M.R., Marcos J.F.V., Pérez A.P., López M.A.B., López A.M., Donaire J.A.G., Obaya J.C., Guerra L.C., Carratalá V.P., Cabello I.E., Lazo M.S., Rodrigo M.M.C., Prieto J.M.M., Doblas J.J.G., Soto A.B.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should a basic lipid profile include?. Neurology Perspectives. 2023; 3(2)DOI:10.1016/j.neurop.2023.100126. PMID:. IF:(Q/D).

Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. Rec: Cardioclinics. 2023; 58(2)DOI:10.1016/j.rccl.2022.11.004. PMID:. IF:(Q/D).

Bellido V., Freckman G., Pérez A., Galindo R.J.. Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital. Endocrine Practice. 2023; 29(11)DOI:10.1016/j.eprac.2023.06.007. PMID:37369291. IF:3.700(Q2/4D).

Niño-Narvión J., Camacho M., Julve J.. NAD+ Precursors: A Physiological Reboot?. Nutrients. 2023; 15(20)DOI:10.3390/nu15204479. PMID:. IF:(Q/D).

Lazarus, JV, Agirre-Garrido, L, Miralles-Sanchez, JE, Manolas, MI, Tacke, F, Villela-Nogueira, CA, Al-Omar, HA, Alqahtani, SA, Alzubaidi, LMY, Bansal, M, Cusi, K, Isaacs, SD, Mauricio, D, Miyake, T, Moreira, RO, Nakazawa, S, Pannain, S, Pericàs, JM, Roden, M, Takahashi, H, Brachowicz, N. Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries. LIVER INTERNATIONAL. 2025; 45(12)DOI:10.1111/liv.70390. PMID:41194401. IF:5.200(Q1/2D).

Giorgino, F, Alzaid, F, Stoian, AP, Chan, JCN, Ji, LN, Lumu, W, Manrique, H, Mauricio, D, Saboo, B, Senior, PA, Yabe, D, Zoungas, S, Meireles, M, Mathieu, C, Czupryniak, L. Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council. DIABETOLOGIA. 2025; 68(11)DOI:10.1007/s00125-025-06504-5. PMID:40928674. IF:10.200(Q1/1D).

Martinez-Brocca, MA, Bellido, V, Cardona-Hernandez, R, Castaño, L, Conget, I, Fernández, A, Gila, ALG, Leiva-Gea, I, Mauricio, D. Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: Consensus of the scientific societies SED, SEEN and SEEP. Endocrinologia Diabetes y Nutricion. 2025; 72(9)DOI:10.1016/j.endinu.2025.501639. PMID:41111054. IF:1.800(Q3/8D).

Takele, WW, Redman, LM, Liu, K, Quinteros, A, Ukke, GG, Tobias, DK, Merino, J, Ahmad, A, Aiken, C, Benham, JL, Bodhini, D, Clark, AL, Colclough, K, Corcoy, R, Cromer, SJ, Duan, DSY, Felton, JL, Francis, EC, Gillard, P, Gingras, V, Gaillard, R, Haider, E, Hughes, A, Ikle, JM, Jacobsen, LM, Kahkoska, AR, Kettunen, JLT, Kreienkamp, RJ, Lim, LL, Männistö, JME, Massey, R, Mclennan, NM, Miller, RG, Morieri, ML, Most, J, Naylor, RN, Ozkan, B, Patel, KA, Pilla, SJ, Prystupa, K, Raghavan, S, Rooney, MR, Schön, M, Semnani-Azad, Z, Sevilla-Gonzalez, M, Svalastoga, P, Tam, CH, Thuesen, ACB, Tosur, M, Wallace, AS, Wang, CC, Wong, JJ, Yamamoto, JM, Young, K, Amouyal, C, Andersen, MK, Bonham, MP, Chen, ML, Cheng, FF, Chikowore, T, Chivers, SC, Clemmensen, C, Dabelea, D, Dawed, AY, Deutsch, AJ, Dickens, LT, Dimeglio, LA, Dudenhöffer-Pfeifer, M, Evans-Molina, C, Fernández-Balsells, MM, Fitipaldi, H, Fitzpatrick, SL, Gitelman, SE, Goodarzi, MO, Grieger, JA, Guasch-Ferré, M, Habibi, N, Hansen, T, Huang, CG, Harris-Kawano, A, Ismail, HM, Hoag, B, Johnson, RK, Jones, AG, Koivula, RW, Leong, A, Leung, GKW, Libman, IM, Long, SA, Lowe, WL, Morton, RW, Motala, AA, Onengut-Gumuscu, S, Pankow, JS, Pathirana, M, Pazmino, S, Perez, D, Petrie, JR, Powe, CE, Jain, R, Ray, D, Ried-Larsen, M, Saeed, Z, Santhakumar, V, Kanbour, S, Sarkar, S, Monaco, GSF, Scholtens, DM, Selvin, E, Sheu, WHH, Speake, C, Stanislawski, MA, Steenackers, N, Steck, AK, Stefan, N, Stoy, J, Taylor, R, Tye, SC, Ukke, GG, Urazbayeva, M, van der Schueren, B, Vatier, C, Wentworth, JM, Hannah, W, White, SL, Yu, GC, Zhang, YC, Zhou, SJ, Beltrand, J, Polak, M, Aukrust, I, de Franco, E, Flanagan, SE, Maloney, KA, Mcgovern, A, Molnes, J, Nakabuye, M, Njolstad, PR, Pomares-Millan, H, Provenzano, M, Saint-Martin, C, Zhang, CL, Zhu, YY, Auh, S, de Souza, R, Fawcett, AJ, Gruber, C, Mekonnen, EG, Mixter, E, Sherifali, D, Eckel, RH, Nolan, JJ, Philipson, LH, Brown, RJ, Billings, LK, Boyle, K, Costacou, T, Dennis, JM, Florez, JC, Gloyn, AL, Gomez, MF, Gottlieb, PA, Greeley, SAW, Griffin, K, Hattersley, AT, Hirsch, IB, Hivert, MF, Hood, KK, Josefson, JL, Kwak, SH, Laffel, LM, Lim, SS, Loos, RJF, Ma, RCW, Mathieu, C, Mathioudakis, N, Meigs, JB, Misra, S, Mohan, V, Murphy, R, Oram, R, Owen, KR, Ozanne, SE, Pearson, ER, Perng, W, Pollin, TI, Pop-Busui, R, Pratley, RE, Redondo, MJ, Reynolds, RM, Semple, RK, Sherr, JL, Sims, EK, Sweeting, A, Tuomi, T, Udler, MS, Vesco, KK, Vilsboll, T, Wagner, R, Rich, SS, Franks, PW, Josefson, J, Lim, S. Participant characteristics in the effectiveness of lifestyle interventions to optimize gestational weight gain: a systematic review and meta-analysis. Communications Medicine. 2025; 5(1)DOI:10.1038/s43856-025-01049-5. PMID:41136661. IF:(Q/D).

Cai, ZC, Najib, S, Núñez-Sánchez, MA, Martínez-Sánchez, MA, García-Melgares, C, Viguerie, N, Rossell, J, Julve, J, Croyal, M, Oliveira, AR, Martínez, CM, Dumas, SJ, Genoux, A, Frutos, MD, Ramos-Molina, B, Martinez, LO. ApoJ and apoL1 as novel determinants of MASH: a cross-sectional study. Lipids in Health and Disease. 2025; 24(1)DOI:10.1186/s12944-025-02733-0. PMID:41088161. IF:4.200(Q1/3D).

Torres-Méndez, JK, Rojo-López, MI, Antentas, M, Vendrell, P, Ortega, E, Alonso, N, Castelblanco, E, Muscarà, A, Rubinat, E, Alcubierre, N, Hernández, M, Rossell, J, Granado-Casas, M, Mauricio, D, Julve, J. Association between dietary niacin intake and diabetic retinopathy in a Catalonian population: a cross-sectional study. Frontiers in Nutrition. 2025; 12DOI:10.3389/fnut.2025.1626379. PMID:41164367. IF:5.100(Q1/2D).